Figure 2.
Relative abundance of cell subpopulations between PBMCs from acute gout patients and either PBMCs from healthy subjects or SF. (A–D) Relative abundance of cell subpopulations in PBMCs from acute gout and healthy subjects. (E–K) Relative abundance of cell subpopulations compared between PBMCs from patients with acute gout and SF samples. The cell subpopulations examined in this comparison were (A–F) monocyte series and (G–K) T and natural killer (NK) cells. *P < 0.05; **P < 0.01.